aap Implantate AG (FRA:AAQ1)

Market Cap	22.81M
Revenue (ttm)	12.29M
Net Income (ttm)	-3.63M
Shares Out	n/a
EPS (ttm)	-0.28
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	767
Open	1.610
Previous Close	1.610
Day's Range	1.610 - 1.610
52-Week Range	1.080 - 2.900
Beta	n/a
RSI	45.73
Earnings Date	Jul 21, 2025

About Revance Therapeutics

aap Implantate AG develops, manufactures, and markets traumatology products for orthopedics in Germany and internationally. The company offers LOQTEQ, an anatomical plating system for the treatment of ankle, straight plates, knee, elbow, wrist, and shoulder. It also provides hole screws and Repro Bone materials. The company sells its products directly to hospitals, purchasing groups, and hospital groups through a network of distributors. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1990
• Employees: 101
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: AAQ1

Financial Performance

In 2024, aap Implantate AG's revenue was 12.29 million, an increase of 5.37% compared to the previous year's 11.67 million. Losses were -3.63 million, -29.17% less than in 2023.